414 a Fitst-In-Human Study of BLZ-100 (Tozuleristide) Demonstrates Tolerability and Fluorescence Contrast in Skin Cancer

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.421

Related search